travoprost 0.004%

DRUG4 trials

Sponsors

Allergan, Alcon Research

Conditions

GlaucomaOcular HypertensionOpen Angle GlaucomaOpen-Angle GlaucomaOpen-angle Glaucoma (OAG)

Phase 2

Travoprost Five Day Posology Study

CompletedNCT01114893

Alcon ResearchOcular Hypertension, Open-angle Glaucoma (OAG)

Start: 2010-04-30Updated: 2011-06-23

Phase 4

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

CompletedNCT00539526

AllerganOcular Hypertension, Open Angle Glaucoma

Start: 2007-09-30End: 2008-09-30Updated: 2019-04-24

Efficacy of Changing to TRAVATAN® From Prior Therapy

CompletedNCT01493427

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-12-31End: 2013-02-28Updated: 2014-05-19

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

CompletedNCT02097719

AllerganGlaucoma, Ocular Hypertension

Start: 2014-05-31End: 2014-12-31Updated: 2016-01-14